Mercer Global Advisors
EVMN

Mercer Global Advisors’s Evommune Inc EVMN Stock Holding History

Mercer Global Advisors’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$186 Buy
+14
New +$325 ﹤0.01% 5925

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mercer Global Advisors's EVMN Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Evommune Inc (EVMN) in Q2 2026: 14 shares worth $186. The stake represents ﹤0.01% of the portfolio and ranks #5925 among its holdings.

51 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

  • Mercer Global Advisors held 14 shares of Evommune Inc worth $186 as of Q2 2026.
  • Evommune Inc was a new Mercer Global Advisors position in Q2 2026.
  • Evommune Inc made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5925 holding.
  • 51 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.